Other languages Dr. Lal PathLabs Limited

Equities

LALPATHLAB

INE600L01024

Delayed NSE India S.E. Other stock markets 07:43:53 2024-05-24 am EDT			5-day change	1st Jan Change
2,626 ^INR	+1.74%		+3.57%	+1.88%

May. 14	Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505	MT
May. 13	Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6%	May. 13
India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand	May. 10
Dr. Lal PathLabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	May. 10
Dr. Lal PathLabs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 10
Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer, Effective May 9, 2024	Apr. 26
Dr Lal Pathlabs Names CEO	Mar. 17
Dr. Lal PathLabs Limited Appoints Shankha Banerjee as Chief Executive Officer, Effective May 21, 2024	Mar. 16
Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer	Mar. 03
Dr. Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q3; EPS, Revenue Miss Estimates	Feb. 01
Dr. Lal PathLabs Seeks M&A	Feb. 01
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	Feb. 01
Dr. Lal PathLabs Limited Approves Second Interim Dividend for the Fiscal Year 2023-24	Feb. 01
Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 01
Dr. Lal Pathlabs Board to Consider Second Interim Dividend for Fiscal 2024	Jan. 25
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q2; Shares Climb 5%	Nov. 03
Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 02
Dr. Lal Pathlabs Limited Approves to Declare Final Dividend for the Financial Year Ended March 31, 2023	23-09-12
Dr. Lal PathLabs Limited Announces Change in Directorate	23-08-20
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q1; Revenue Meets Estimates	23-07-31
Dr. Lal PathLabs Seeks Inorganic Opportunity	23-07-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Dr. Lal PathLabs Limited

Equities

LALPATHLAB

INE600L01024

Other languages

Filters